Cinqaero 100 mg/10 mL, Konzentrat zur Herstellung einer Infusionslösung

7680663400039 CH-66340 Konzentrat
Cinqaero 100 mg/10 mL, Konzentrat zur Herstellung einer Infusionslösung
Cinqaero 100 mg/10 mL, Konzentrat zur Herstellung einer Infusionslösung
Cinqaero 100 mg/10 mL, Konzentrat zur Herstellung einer Infusionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Konzentrat
Galenic group
Tinkturen/Desinfektion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
14/06/2023
Summary of Product Characteristics
Français
14/06/2023
Summary of Product Characteristics
Italien
14/06/2023

Detailed composition

Substance Quantity Type Category
(N/A)
100.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.41 MG Substance HBESI

Reimbursement information

Public price
CHF 633.30
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/06/2018

Authorization holder

Teva Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
66340
Drug name
Cinqaero, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOINF
ATC Code
R03DX08
Authorization status
Z
Dispensing category
B
First authorization
09/11/2017
Authorization expiration date
31/12/9999
IT Number
03.04.5.
Domain
Human medicine
Field of application
Zusatztherapie bei schwerem eosinophilem Asthma bei Erwachsenen

Package details

Description (FR)
CINQAERO conc perf 100 mg/10ml flac 10 ml
Description (DE)
CINQAERO Inf Konz 100 mg/10ml Durchstf 10 ml
Market launch
09/11/2017
Narcotic (BTM)
No

Other package sizes (2)

CINQAERO conc perf 10 mg/1ml flac 10 ml
None None
GTIN: 7680663400015
Not in V1
CINQAERO conc perf 25 mg/2.5ml flac 2.5 ml
1 DUR
GTIN: 7680663400022
View